NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-090-2002-1-HK-09 Assays For Assembly Of Ebola Virus Nucleocapsids HK National Stage 05107248.0 Abandoned
NCI E-087-2004-0-JP-05 Novel And Stable Pharmaceutical Formulations Of L-threo-dihydrosphingosine ("Safingol") f JP National Stage 2006-503721 Expired
NCI E-087-2004-0-MX-04 Novel And Stable Pharmaceutical Formulations Of L-threo-dihydrosphingosine ("Safingol") MX National Stage PA/A/2005008860 Expired
NCI E-276-2002-0-US-06 NOVEL NITRIC OXIDE-RELEASING AMIDINE DIAZENIUMDIOLATES, COMPOSITIONS AND USES THEREOF AND METHOD OF MAKING SAME US DIV 11/208,313 7348319 Abandoned PDF
NCI E-134-2000-0-US-03 Utilization of Non-viral Sequences For Minus-strand DNA Transfer and Gene Reconstitution US DIV 11/208,436 Abandoned
NCI E-238-2005-0-US-01 Topical Formulations Of Histone Deacetylase Inhibitors and Methods of Using the Same US 60/709,553 Abandoned
NCI E-057-1994-3-DE-15 MELANOMA ANTIGENS DE EP 05018103.1 Expired
NCI E-057-1994-3-FR-14 MELANOMA ANTIGENS FR EP 05018103.1 Expired
NCI E-057-1994-3-GB-13 MELANOMA ANTIGENS GB EP 05018103.1 Expired
NCI E-152-1991-1-JP-28 Composite Synthetic Peptide Construct Eliciting Neutralizing Antibodies and Cytotoxic T Lymphocytes Against HIV JP DIV 2005-238013 Abandoned
NCI E-196-1992-3-JP-08 BIOPOLYMER-BOUND NITRIC OXIDE/NUCLEOPHILE ADDUCT COMPOSITIONS, PHARMACEUTICAL COMPOSITIONS INCORPORATING SAME AND METHODS OF.... JP DIV 2005-236706 Abandoned
NCI E-217-2005-0-US-01 Antibodies Against Insulin-Like Growth Factor II and Uses Thereof US 60/709,226 Abandoned
NCI E-148-2007-2-US-13 Nucleotide sequences derived from the env gene of HIV-1 US CON 11/203,127 7777020 Expired PDF
NCI E-113-2003-1-US-01 Target Activated Microtransfer US CIP 11/202,848 7695752 Expired PDF
NIAID E-040-1999-0-AU-14 Production of Attenuated Negative Stranded RNA Virus Vaccines From Cloned Nucleotide Sequences AU DIV 2005203596 Abandoned
NCI E-033-1999-0-US-04 High Speed Parallel Molecular Nucleic Acid Sequencing US DIV 11/204,367 Abandoned
NIA E-354-2004-0-JP-06 Biomarkers for Osteoarthritis JP National Stage 2007-527900 Abandoned
NIA E-354-2004-0-PCT-02 Biomarkers for Osteoarthritis PCT PCT PCT/US2005/028871 Expired
NIA E-354-2004-0-EP-05 Biomarkers for Osteoarthritis EP National Stage 05788062.7 Abandoned
NIMH E-294-2005-0-US-01 A Neuronal Avalanche Size (NAS) Assay To Screen For Cognitive Enhancers And Anti-Epileptics US 60/707,651 Abandoned
NCI E-275-2005-0-US-01 Novel Molecular Scaffolds Are Broad-spectrum Antibiotics US 60/707,531 Abandoned
NIMH E-181-2005-0-US-01 Neuregulin1-induced Chemotaxis (or Cell Migration) Assay Using Tumor- Or Blood- Derived Cells And Cancer Research And Practice US 60/707,714 Abandoned
NIA E-354-2004-0-AU-03 Biomarkers for Osteoarthritis AU National Stage 2005277559 Abandoned
NIA E-354-2004-0-CA-04 Biomarkers for Osteoarthritis CA National Stage 2575439 Abandoned
NINDS E-143-2002-1-HK-08 Method For the Treatment of Multiple Sclerosis HK National Stage 05106924.3 Abandoned
NIAID E-178-1999-1-US-03 Production of Attenuated, Human-Bovine Chimeric Respiratory Syncytial Virus Vaccines US CON 11/203,620 7842798 Abandoned PDF
NCI E-258-2005-0-US-01 Method for Determining Redox Status of a Tissue US 60/707,518 Abandoned
NEI E-185-1992-3-US-03 PIGMENT EPITHELIUM DERIVED FACTOR: CHARACTERIZATION GENOMIC ORGANIZATION AND SEQUENCE OF THE PEDF GENE US DIV 11/201,443 Abandoned
NCI E-317-2004-1-PCT-02 Synthetic Metal Ion Chelating Amino Acid Suitable For Use In Solid Phase Peptide Synthesis PCT PCT PCT/US2005/028125 Expired
NIAMS E-247-1988-0-US-06 Polypeptide and DNA Sequence Corresponding to the Human Receptor with High Affinity for IgE US REISSUE 11/272,966 Abandoned
NHGRI E-055-2005-1-US-01 Methods And Use Of Farnesyl Transferase Inhibitors (FTIs) For Laminopathies, Cellular Aging, And Artherosclerosis US 60/707,192 Abandoned
CC E-170-2004-0-EP-03 Second Generation Integrin Avb3 Antagonists For Use In Imaging And Therapy EP National Stage 05807519.3 Issued
NHLBI E-120-2003-2-US-01 Method of Inducing Memory B Cell Development and Terminal Differentiation US CIP 11/197,221 7378276 Issued PDF
CC E-170-2004-0-PCT-02 Second Generation Integrin Avb3 Antagonists For Use In Imaging And Therapy PCT PCT PCT/US2005/027868 Expired
NCI E-324-2001-2-PCT-02 Prediction Of Clinical Outcome Using Gene Expression Profiling And Artificial Neural Networks For Patients With Neuroblastoma PCT PCT PCT/US2005/027660 Abandoned
NINDS E-091-2003-0-US-04 Tissue Transglutinase Inhibition As A Therapeutic Strategy In Parkinson's Disease And Other A-Synucleinopathies US National Stage 10/544,326 Abandoned
NCI E-094-1994-0-US-04 JANUS FAMILY KINASES AND IDENTIFICATION OF IMMUNE MODULATORS (JAK-3) US DIV 11/195,197 7488808 Abandoned PDF
NCI E-223-1998-0-US-04 P53 and VEGF Regulate Tumor Growth of NOS2 Expressing Cancer Cells US DIV 11/195,006 Abandoned
NIDDK E-236-2002-0-US-07 NOVEL PEPTIDE INHIBITOR OF HIV FUSION THAT DISRUPTS THE INTERNAL TRIMERIC COILED-COIL OF GP41 US National Stage 10/544,115 Abandoned
NCI E-211-2005-0-US-01 Use of Chk2 Kinase Inhibitors for Cancer Treatment US 60/703,556 Abandoned
NCI E-262-2005-0-US-01 Mutated Pseudomonas Exotoxins with Reduced Antigenicity US 60/703,798 Abandoned
NIDDK E-167-2005-0-US-01 System and methods for detecting and characterizing macromolecular interactions in solution US 60/703,814 Abandoned
NCI E-226-2004-0-US-02 Metastasis Suppressor Gene On Human Chromosome 8 And Its Use In The Diagnosis, Prognosis, And Treatment Of Cancer US ORD 11/190,027 Abandoned
NCI E-097-2004-1-US-01 Layered Peptide/antigen Arrays US CIP 11/189,038 Abandoned
NIA E-116-2004-0-PCT-02 Coacervate Microparticles Useful for the Sustained Release Administration of Therapeutic Agents PCT PCT PCT/US2005/026257 Expired
NIEHS E-298-1999-1-US-05 Soluble Epoxide HydrolaseInhibitors As Novel Therapeutic Agents For Management Of Systemic Hypertension US CON 11/189,964 Abandoned
NICHD E-225-1997-7-US-01 Methods And Compositions For The Treatment Of Fribrotic Conditions & Impaired Lung Function & To Enchance Lyphocyte Production US CIP 11/189,229 Abandoned
NCI E-113-2003-0-US-03 Target Activated Microtransfer US National Stage 10/543,218 7709047 Issued PDF
NIDCD E-344-2002-0-US-03 Peptide Mimotopes of Lipooligosaccharide from Nontypeable Haemophilus Influenzae as Vaccines US National Stage 11/187,419 7514529 Expired PDF
NIA E-262-2003-0-PCT-02 USES OF NOTCH RECEPTORS, NOTCH LIGANDS, AND NOTCH MODULATORS IN METHODS RELATED TO THE METABOLIC DISEASES PCT PCT PCT/US2005/026267 Expired